Extended Use of an Open-Source Automated Insulin Delivery System in Children and Adults With Type 1 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Technology & Therapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Extended Use of an Open-Source Automated Insulin Delivery System in Children and Adults with Type 1 Diabetes: The 24-Week Continuation Phase Following the CREATE Randomized Controlled Trial
Diabetes Technol. Ther. 2023 Apr 01;25(4)250-259, MJ Burnside, DM Lewis, HR Crocket, RA Meier, JA Williman, OJ Sanders, CA Jefferies, AM Faherty, RG Paul, CS Lever, SKJ Price, CM Frewen, SD Jones, TC Gunn, C Lampey, BJ Wheeler, MI de BockFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.